Department of Biotechnology

About: Department of Biotechnology is a government organization based out in New Delhi, India. It is known for research contribution in the topics: Population & Silver nanoparticle. The organization has 4800 authors who have published 5033 publications receiving 82022 citations.

Screening for enantioselective nitrilases : Kinetic resolution of racemic mandelonitrile to (R)-(-)-mandelic acid by new bacterial isolates

Abstract: Several new microorganisms have been isolated with high nitrilase activity against ( RS )-mandelonitrile using the enrichment culture technique. The organisms were cultivated in liquid culture and the enzyme activity was determined at different phases of growth. The organisms having high enzyme titre were further grown and used as catalysts for the transformation of mandelonitrile to mandelic acid. The percentage conversion was checked with RP-HPLC and the enantiomeric excess was determined on a chiral column. Three isolates gave the desired product, ( R )-(−)-mandelic acid with high ee (%) and were identified as Pseudomonas putida , Microbacterium paraoxydans and Microbacterium liquefaciens . All three isolates showed good specific activity (0.33–0.50 U/mg min) with high ee (>93%) and E values. The conversion of racemic mandelonitrile to mandelic acid by these isolates was compared: P. putida was found to be the most suitable biocatalyst for further studies as it showed higher reaction rate ( k Rxn ), lower K m , better growth rate ( μ ), good yield and ee values and higher stability compared to the other two microorganisms.

The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.

Abstract: The cellular quality control system degrades abnormal or misfolded proteins and consists of three different mechanisms: the ubiquitin proteasomal system (UPS), autophagy and molecular chaperones. Any disturbance in this system causes proteins to accumulate, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer's disease (AD), Parkinson's disease, Huntington's disease and prion or polyglutamine diseases. Alzheimer's disease is currently one of the most common age-related neurodegenerative diseases. However, its exact cause and pathogenesis are unknown. Currently approved medications for AD provide symptomatic relief; however, they fail to influence disease progression. Moreover, the components of the cellular quality control system represent an important focus for the development of targeted and potent therapies for managing AD. This review aims to evaluate whether existing evidence supports the hypothesis that UPS impairment causes the early pathogenesis of neurodegenerative disorders. The first part presents basic information about the UPS and its molecular components. The next part explains how the UPS is involved in neurodegenerative disorders. Finally, we emphasize how the UPS influences the management of AD. This review may help in the design of future UPS-related therapies for AD.